|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
Lung Cancer Screen 29 Tissue Microarray - LS-SLUCA29
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SLUCA29 |
| Product Name: |
Lung Cancer Screen 29 |
| Description: |
Lung cancer with stage/grade |
| Format: |
FFPE |
| Category: |
Human Tumor |
| QA/QC: |
H&E reviewed |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
5 µm |
| Cases: |
11 |
| Cores: |
11 |
| Slides Per Set: |
1 |
LS-SLUCA29 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | | A | Lng | Lng | Lng | Lng | Lng | Lng | | B | Lng | Lng | Lng | Lng | Lng | |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendLung (Lng);
LS-SLUCA29 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Stage | Tumor Grade |
|---|
| 1 | A1 | Human | F | 54 y | Lung (Lng) | Adenocarcinoma with necrosis | Malignant | T3N0M0 | IIIA | |
| 1 | A2 | Human | M | 49 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | I | 3 |
| 1 | A3 | Human | M | 70 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | I | 1-2 |
| 1 | A4 | Human | M | 44 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | II | 2 |
| 1 | A5 | Human | M | 76 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | II | 1 |
| 1 | A6 | Human | M | 68 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | I | 2 |
| 1 | B1 | Human | M | 50 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N0M0 | IIIA | 2 |
| 1 | B2 | Human | M | 48 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | I | 2 |
| 1 | B3 | Human | M | 56 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N0M0 | IIIA | 2 |
| 1 | B4 | Human | M | 61 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | I | 3 |
| 1 | B5 | Human | M | 69 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T1N0M0 | I | 2 |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
